Literature DB >> 4116504

Some immunological interactions between mother and foetus.

C A Clarke.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4116504      PMCID: PMC2539053     

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  28 in total

1.  STUDIES ON THE SOURCE OF ANTIGENIC STIMULATION IN THE INDUCTION OF TOLERANCE BY PARITY.

Authors:  J B PORTER; E J BREYERE
Journal:  Transplantation       Date:  1964-03       Impact factor: 4.939

2.  Horse blood groups and hemolytic disease of the newborn foal.

Authors:  D FRANKS
Journal:  Ann N Y Acad Sci       Date:  1962-05-03       Impact factor: 5.691

3.  Choriocarcinoma. Observations on the etiology.

Authors:  J S SCOTT
Journal:  Am J Obstet Gynecol       Date:  1962-01-15       Impact factor: 8.661

4.  ABO blood-groups in trophoblastic neoplasia.

Authors:  K D Bagshawe; G Rawlins; M C Pike; S D Lawler
Journal:  Lancet       Date:  1971-03-20       Impact factor: 79.321

5.  Histocompatibility antigens in choriocarcinoma.

Authors:  J S Scott
Journal:  Lancet       Date:  1968-04-20       Impact factor: 79.321

6.  Prolonged cancine renal allograft survival after pretreatment with solubilized antigen.

Authors:  R E Wilson; A Rippin; R K Dagher; P Kinneart; G J Busch
Journal:  Transplantation       Date:  1969-05       Impact factor: 4.939

7.  Immunosuppression by antibody.

Authors:  R J Ryder; L K Kilham; R S Schwartz
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

8.  Prevention of haemolytic disease of the newborn.

Authors:  J M Bowman
Journal:  Br J Haematol       Date:  1970-12       Impact factor: 6.998

9.  HOMEOSTASIS OF ANTIBODY FORMATION IN THE ADULT RAT.

Authors:  D A ROWLEY; F W FITCH
Journal:  J Exp Med       Date:  1964-12-01       Impact factor: 14.307

10.  The incidence of allergic disorders and cancer.

Authors:  W D Mackay
Journal:  Br J Cancer       Date:  1966-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.